RYSTIGGO 140 mg/mL, solution injectable

ReimbursedATC L04AG16

Last synced from Base de données publique des médicaments — BDPM (France) on June 3, 2026

Identification

ManufacturerUCB PHARMA BELGIQUE

CountryFR (France)

ATC codeL04AG16

Dispensing—

ReimbursedYes

SourceBase de données publique des médicaments — BDPM (France)

Last synced6/3/2026

Packs · 3

cip13
3400930284742
1 flacon en verre de 2 mL
EUR 7.32
cip13
3400930300763
1 flacon en verre de 3 mL
EUR 10.91
cip13
3400930300770
1 flacon en verre de 4 mL
EUR 14.51

Annotations

No annotations yet.

Raw payload (JSON)

{
  "cis": "68822785",
  "date_amm": "2024-01-05",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/23/1780",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

Related drugs

Other records sharing ATC code L04AG16.

Access this data programmatically

Query RYSTIGGO 140 mg/mL, solution injectable and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs